| Schedule of revenue recognition |
Revenue
by Service Line
| |
|
Three
Months Ended June 30, |
| |
|
2019 |
|
2018 |
| Products: |
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
|
| Functional
neurosurgery |
|
$ |
1,690,122 |
|
|
$ |
1,159,527 |
|
| Biologics
and drug delivery |
|
|
244,949 |
|
|
|
111,792 |
|
| Therapy |
|
|
17,830 |
|
|
|
- |
|
| Capital
equipment |
|
|
241,293 |
|
|
|
141,280 |
|
| Total
product revenue |
|
|
2,194,194 |
|
|
|
1,412,599 |
|
| Services: |
|
|
|
|
|
|
|
|
| Capital
equipment and other |
|
|
243,954 |
|
|
|
71,736 |
|
| Biologics
and drug delivery |
|
|
168,250 |
|
|
|
162,000 |
|
| Total
service revenue |
|
|
412,204 |
|
|
|
233,736 |
|
| Total
revenue |
|
$ |
2,606,398 |
|
|
$ |
1,646,335 |
|
| |
|
Six
Months Ended June 30, |
| |
|
2019 |
|
2018 |
| Products: |
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
|
| Functional
neurosurgery |
|
$ |
3,294,767 |
|
|
$ |
2,338,862 |
|
| Biologics
and drug delivery |
|
|
529,859 |
|
|
|
292,258 |
|
| Therapy |
|
|
17,830 |
|
|
|
- |
|
| Capital
equipment |
|
|
515,692 |
|
|
|
320,078 |
|
| Total
product revenue |
|
|
4,358,148 |
|
|
|
2,951,198 |
|
| Services: |
|
|
|
|
|
|
|
|
| Capital
equipment and other |
|
|
455,156 |
|
|
|
156,504 |
|
| Biologics
and drug delivery |
|
|
265,611 |
|
|
|
162,000 |
|
| Total
service revenue |
|
|
720,767 |
|
|
|
318,504 |
|
| Total
revenue |
|
$ |
5,078,915 |
|
|
$ |
3,269,702 |
|
|